TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
4.390
+0.050 (1.15%)
At close: Sep 28, 2026, 4:00 PM EDT
4.320
-0.070 (-1.59%)
After-hours: Sep 28, 2026, 4:18 PM EDT
TriSalus Life Sciences Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, TriSalus Life Sciences stock has a consensus rating of "Strong Buy" and an average price target of $10.4. The average 1-year stock price forecast is 136.90% higher than the current stock price, while the lowest is $7.00 (+59.45%) and the highest is $14 (+218.91%).
Price Target: $10.4 (+136.90%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for TriSalus Life Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 3 | 3 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 4 | 4 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Buy Maintains $7 | Buy | Maintains | $7 | +59.45% | Sep 23, 2026 |
| Lake Street | Lake Street | Buy Reiterates $8 | Buy | Reiterates | $8 | +82.23% | Sep 23, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $12 | Buy | Reiterates | $12 | +173.35% | Sep 22, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $10 → $14 | Buy | Reiterates | $10 → $14 | +218.91% | Aug 11, 2026 |
| JonesTrading | JonesTrading | Buy Reiterates $11 | Buy | Reiterates | $11 | +150.57% | Aug 10, 2026 |
Financial Forecast
Revenue This Year
53.12M
from 45.15M
Increased by 17.65%
Revenue Next Year
74.51M
from 53.12M
Increased by 40.27%
EPS This Year
-0.45
EPS Next Year
-0.25
from -0.45
EPS and Forward PE are based on non-GAAP adjusted numbers.